facebook


Go ProSubmit a deal
Submit
Series ASword Health

Sword Health Raises $40 Million In Series A Funding At $4 Billion Valuation

Sword Health, a New York-based AI care company led by founder and CEO Virgilio Bento, has raised $40 million in Series A funding at a $4 billion valuation. Backed by General Catalyst, Khosla Ventures , Comcast Venture…

By TradedVC Editorial1 min read
Sword Health Raises $40 Million In Series A Funding At $4 Billion Valuation

Sword Health, a New York-based AI care company led by founder and CEO Virgilio Bento, has raised $40 million in Series A funding at a $4 billion valuation. Backed by General Catalyst, Khosla Ventures, Comcast Ventures, and others, the funding will support the company’s M&A strategy, global expansion, and AI model development. Sword Health’s platform enables AI-first care for physical and mental health, recently launching “Mind,” a continuous mental health solution that blends AI and clinicians. The company has delivered over 6.5 million AI sessions to 500,000+ members since 2020, helping over 1,000 enterprise clients reduce nearly $1 billion in healthcare costs.

INVESTORS: General Catalyst, Khosla Ventures, Comcast Ventures, Lince Capital, Oxy Capital, Armilar, Indico Capital & Shilling

ROUND: Series A AMOUNT: $40,000,000 VALUATION: $4,000,000,000

HQ: #NewYork #NY #NewYorkCity #NYC

#VentureCapital #SwordHealth #GeneralCatalyst #KhoslaVentures #ComcastVentures #LinceCapital #OxyCapital #Armilar #IndicoCapital #Shilling #TradedVC

ABOUT THE DEAL

Raise
$40M
Round
Series A
Company
Sword Health
Desk
Deals
Filed
Jun 19, 2025
Investors
  • General Catalyst
  • Khosla Ventures
  • Comcast Ventures
  • Lince Capital
  • Oxy Capital
  • Armilar
  • Indico Capital
  • Shilling
ALL DEALS
Deal

Nooks Secures $500 Million In Funding From General Catalyst’s Customer Value Fund

Nov 4, 2026

Deal

Sentra Secures $150 Million In Strategic Investment Led By Capital One Ventures

Nov 4, 2026

Deal

Phaze Secures $8.75 Million In Seed Funding Led By Andreessen Horowitz

Nov 4, 2026